- Unit no.906, T3 block Golden I, Tech Zone 4, Graeter Noida
Pharmaceutical intermediates are chemical compounds used during the synthesis of Active Pharmaceutical Ingredients (APIs). These intermediates play a crucial role in the production process, serving as building blocks that undergo further chemical reactions to form the final therapeutic compound. Their quality and purity are essential in ensuring the efficacy and safety of the resulting API. In the pharmaceutical industry, intermediates must meet stringent regulatory standards to ensure consistency and avoid contaminants. Pharmabridge helps bridge the gap in access to high-quality intermediates by promoting collaborations between manufacturers, regulatory bodies, and suppliers. By enhancing the supply chain and facilitating knowledge exchange, Pharmabridge enables pharmaceutical companies, particularly in developing regions, to produce cost-effective, high-quality medicines, ultimately improving global healthcare outcomes.
| INTERMEDIATESA1:D16A76A1:D81 | |||
| SR. NO. | API | INTERMEDIATES | CAS NO |
| ONCOLOGY INTERMEDIATES | |||
| 2 | Etoposide | Podophyllotoxin 50% | 518-28-5 |
| Podophyllotoxin 98% | 518-28-5 | ||
| 4 de methyl epi Podophyllotoxin | 6559-91-7 | ||
| 2 | Imatinib Mesylate | Imatinb Base | 152459-95-5 |
| 4-[(4-Methylpiperazin-1- yl)methyl]benzoic acid dihydrochloride | 106261-49-8 | ||
| N-(5-Amino-2-methylphenyl)-4-(3- pyridyl)-2- pyrimidine amine | 152460-10-1 | ||
| 3 | Bortezomib | N-[(1S)-2-[[(1R)-1-[(3as,4S,6S,7ar)- Hexahydro-3a,5,5-trimethyl-4,6-methano- 1,3,2-benzodioxaborol-2-yl]-3- methylbutyl]amino]-2-oxo-1- (phenylmethyl) ethyl]-2- pyrazinecarboxamide Bortezomib N-2 stage intermediate | 205393-22-2 |
| (R) –Boroleu-(+)-Pinanediol Trifluoroacetate | 179324-87-9 | ||
| N-(2-Pyrazinylcarbonyl)-L-phenylalanine | 114457-94-2 | ||
| N-1 Bortezomib | |||
| 4 | Gefitinib | 7-Methoxy-6-(3-morpholinopropoxy)-3,4- dihydroquinazolin-4-one (N-1) | 199327-61-2 |
| 5 | Axitinib | 6-Nitro-1H-indazole | 7597-18-4 |
| 2-Mercapto-N-methylbenzamide | 20054-45-9 | ||
| 9,9-Dimethyl-4,5- bis(diphenylphosphino)xanthene | 161265-03-8 | ||
| 2-Vinyl pyridine | |||
| 6 | Gemcitabine | 2′,2′-Difluoro-2′-deoxycytidine-3′,5′- dibenzoate (T9) | 134790-39-9 |
| 7 | Pazopanib | N-(2-chloropyrimidin-4-yl)-N,2,3- trimethyl-2H-indazol-6-amine (N-1) | 444731-75-3 |
| 8 | Sunitinib | 5-Fluoro-2-Oxindole | 56341-41-4 |
| 5-formyl-2,4-dimethyl-1H-pyrrole-3- carboxylic acid | 253870-02-9 | ||
| 9 | Ibrutinib | Ibrutinib N-1 | 1022150-11-3 |
| 3-(4-Phenoxy Phenyl)-1H-pyrazole [3,4-d] pyrimidin-4-Amine | 330786-24-8 | ||
| 10 | Lapatinib | N-[3-Chloro-4-(3- fluorobenzyloxy)phenyl]-6- iodoquinazolin-4-amine | 231278-20-9 |
| 11 | Pemetrexed | Diethyl L-glutamate hydrochloride | 1118-89-4 |
| 2-Chloro-4,6-dimethoxy-1,3,5-triazine | 3140-73-6 | ||
| 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H- pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid (EBA) | 137281-39-1 | ||
| 12 | Bendamustin HCL | 1-Methyl-5-amino-1H-benzimidazole-2- butanoic acid ethyl ester | 3543-73-5 |
| 13 | Irinotecan | 1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride | 143254-82-4 |
| 14 | Lenalidomide | 3-(4-nitro-1-oxo-1, 3-dihydrosoindol-2-yl, piperidine-2, 6-dione | 827026-45-9 |
| 2-(Bromomethyl)-3-Nitrobenzoic Acid Methyl Ester | 98475-07-1 | ||
| 3-Aminopiperidine-2,6-dione Hydrochloride | 24666-56-6 | ||
| 2-Methyl-3-nitrobenzoic Acid | 1975-50-4 | ||
| 3-Amino 2-Methyl Benzoic Acid | 52130-17-3 | ||
| 15 | Temozolomide | 5-Amino-N1-methyl-1H-imidazole-1,4 – dicarboxamide | 188612-53-5 |
| 16 | Temozolomide / Dacarbazine | 5-Amino-4-imidazolecarboxamide Hydrochloride | 72-40-2 |
| 17 | Letrazole | 4-(1H-1,2,4 Trizole-1-ylmethyl) Benzonitrile (N-1) | 112809-25-3 |
| 18 | Zoledronic Acid | Imadazole acetic acid Hcl | 3251-69-2 |
| 19 | Cytarabine | Cyclocytidine HCL | 10212-25-6 |
| 20 | Methotrexate | L-Glutamic acid diethyl ester hydrochloride | 1118-89-4 |
| 2,4,5,6-Tetraaminopyrimidine sulfate | 5392-28-9 | ||
| 4-(Methylamino)benzoic Acid | 10541-83-0 | ||
| 2,4-Diamino-6-(hydroxymethyl)petridine | 945-24-4 | ||
| 6-(Chloromethyl)pteridine-2,4-diamine monohydrochloride | 82778-08-3 | ||
| N-[4-(Methylamino)benzoyl]-L-glutamic acid zinc salt | 66104-81-2 | ||
| Methotrexate Disodium salt (Crude) | 7413-34-5 | ||
| 21 | Abiraterone | 17 iodo andrasta 5,16, dien3b-Ol (Abiraterone Base) | 154229-19-3 |
| 22 | Melphalan | Ethyl Ester of N-Phthaloyl P-Amino-Lphenylalanine | 74743-23-0 |
| 23 | Chlorambucil | P-Amino Phenyl Butyric Acid | 15118-60-2 |
| 24 | Lomustine | 1-(2-chloroethyl) 3-cyclo Hexyl nitroso urea | 13010-47-4 |
| GENERAL INTERMEDIATES | |||
| 1 | Vonoprazan | 5-(2-Fluorophenyl)-1H-pyrrole-3- carbaldehyde (Main Chain) | 881674-56-2 |
| Pyridine-3-sulfonyl chloride hydrochloride (Side Chain) | 16133-25-8 | ||
| 5-(2-fluorophenyl)-1-(pyridin-3- ylsulfonyl)-1H-pyrrole-3-carbonitrile | 881677-11-8 | ||
| 2 | Ropivacaine | (2S)-N-(2,6-Dimethylphenyl)-2- piperidinecarboxamide (N-1) | 27262-40-4 |
| 3 | Vecuronium Bromide | 2 16-dipiperidin-1-ylandrosta-3 17-diol | 13522-6-2 |
| 4 | Tranexamic Acid | 4-(Aminomethyl)benzoic Acid | 56-91-7 |
| 5 | Modafinil | 2[(Diphenylmethyl)thio]acetic Acid, | 63547-22-8 |
| 6 | Neostigmine Methylsulfate & Neostigmine Bromide | 3-Dimethylaminophenol (DMAP) | 99-07-0 |
| 7 | Suxamethonium Chloride | Succinyl Chloride | 543-20-4 |
| 8 | Cinnarzine & Funnarzine | Cinnamyl alcohol | 104-54-1 |